These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25115435)

  • 1. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
    Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
    Jiang H; Yang LY
    Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
    Wu X; Fan W; Xu S; Zhou Y
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5874-9. PubMed ID: 14676109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.
    van Huis-Tanja LH; Kweekel DM; Lu X; Franken K; Koopman M; Gelderblom H; Antonini NF; Punt CJ; Guchelaar HJ; van der Straaten T
    Mutat Res; 2014 Jan; 759():37-44. PubMed ID: 24220697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
    Boulikas T
    Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer.
    Priya Doss CG; Nagasundaram N
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1265-81. PubMed ID: 24158589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
    Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.
    Jordheim LP; Chettab K; Cros-Perrial E; Matera EL; Dumontet C
    Pharmacology; 2018; 102(3-4):161-168. PubMed ID: 30048976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of nucleotide-excision repair genes may contribute to sperm DNA fragmentation and male infertility.
    Gu A; Ji G; Zhou Y; Long Y; Shi X; Fu G; Wang S; Song L; Wang X
    Reprod Biomed Online; 2010 Nov; 21(5):602-9. PubMed ID: 20864414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
    Deng XD; Gao Q; Zhang W; Zhang B; Ma Y; Zhang LX; Muer C; Xie Y; Liu Y
    J Forensic Leg Med; 2017 Jul; 49():15-19. PubMed ID: 28486142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression.
    Yagi T; Katsuya A; Koyano A; Takebe H
    Mutagenesis; 1998 Nov; 13(6):595-9. PubMed ID: 9862190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.